Established Chemistry & Engineering Technology Center in Zhejiang

Inspected by FDA during July 01-05,2019, with no 483s Form issued.

Established PharmaBlock Zhejiang GMP pilot & manufacturing site by partial acquisition

Established Pennsylvania Facility for customer services and process R&D

IPO and listed on Shenzhen Stock Exchange

Established PharmaBlock Shandong pilot & manufacturing site by acquisition

Established PharmaBlock USA in San Francisco

Officially operated